PCI Pharma Services, (“PCI”) a global contract development and manufacturing organisation (CDMO) focused on biopharma’s most complex therapies, is investing more than $365 million in infrastructure.
Antares Vision Group, a technological partner in the digitalisation of products and supply chains for companies and institutions, will introduce a new traceability solution for pharmaceutical bottles at Pack Expo, 3-6th November in Chicago.
Molex, parent company of Phillips Medisize, has announced that it has signed an agreement to purchase Vectura Group Limited, a leader in inhalation drug device design and formulation.
A peer reviewed study published in Frontiers in Neuroscience has shown that Ellorarxine, a novel drug compound developed by biotech spinout Nevrargenics, has shown a robust neuroprotective effect in cultured cells and reaches its target in animals.
DevCo Partners Ltd has announced a capital raise resulting in 616 MEUR of total commitments for its long-term single asset investment vehicle for Medix Biochemica.
The solution aims to efficiently capture cell-free DNA directly from bodily fluids to improve early disease detection, treatment monitoring, and personalised medicine.
Bayer is taking a step in the emerging healthy-ageing space by offering consumers new tools to help them support their healthy-ageing journey with its new Age Factor ecosystem.
